Semaglutide as a promising antiobesity drug.

导出 LinkOut

翻译打印收藏纠错

作者： Georgios A,Christou ^[1] ; Niki,Katsiki ^[2] ; John,Blundell ^[3] ; Gema,Fruhbeck ^[4] ; Dimitrios N,Kiortsis ^[1]

作者单位： School of Medicine, University of Ioannina, Ioannina, Greece. ^[1] Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece. ^[2] Institute of Psychological Sciences, Faculty of Medicine and Health, University of Leeds, Leeds, UK. ^[3] Metabolic Research Laboratory, Clinica Universidad de Navarra, CIBEROBN, Pamplona, Spain. ^[4]

关键词 glucagon-like peptide-1 receptor agonist obesity semaglutide weight loss

主题词减肥药(Anti-Obesity Agents);胰高血糖素样肽类(Glucagon-Like Peptides);人类(Humans);肥胖症(Obesity)

DOI 10.1111/obr.12839

PMID 30768766

发布时间 2020-04-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交